12-51889474-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182608.4(ANKRD33):c.629G>A(p.Arg210Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182608.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152186Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 250678 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461646Hom.: 0 Cov.: 34 AF XY: 0.00000825 AC XY: 6AN XY: 727126 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74466 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.629G>A (p.R210Q) alteration is located in exon 4 (coding exon 4) of the ANKRD33 gene. This alteration results from a G to A substitution at nucleotide position 629, causing the arginine (R) at amino acid position 210 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at